drugset
drugset / Trial / NCT06487949

Valsartan and Amlodipine in Blood Pressure Management: Fixed-Dose vs. Free Drug Therapy

NCT06487949 ↗

Phase 4 Completed 114 enrolled Shiraz University of Medical Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Patients aged 35 to 70 years with newly diagnosed stage 1 or 2 hypertension ( HTN) was randomized to receive either Valsartan 80 mg/Amlodipine 5 mg fix dose combination (FDC) or a free equivalent combination. Ambulatory blood pressure monitoring at baseline and 8 weeks post-treatment initiation was performed.

Timeline

Start
2022-12-01
Primary completion
2023-10-01
Completion
2023-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg —
Subject Valsartan Small molecule 80 mg —

Indications

hypertensive disorder